Clinical Trials Logo

Diabetes clinical trials

View clinical trials related to Diabetes.

Filter by:

NCT ID: NCT03713502 Not yet recruiting - Diabetes Clinical Trials

Enteropathy and Diabetes in HIV Patients

REEHAD
Start date: November 2018
Phase:
Study type: Observational

Emerging data suggest that HIV-infected people have disproportionately higher risk of diabetes than HIV-uninfected people. Multiple factors may contribute to elevated diabetes risk including increased prevalence of conventional non-communicable diseases (NCDs) risk factors, use of some antiretroviral drugs regimens, and inflammation and immune activation secondary to environmental- and HIV-enteropathy. To date, enteropathy has been little studied in relation to HIV and diabetes in Sub-Saharan Africa. Enteropathy leads to systemic inflammation which may in turn result in insulin resistance and may reduce secretion of incretins, the gut hormones which stimulate synthesis and secretion of insulin. Both mechanisms could potentially result in higher diabetes risk in HIV patients. This study investigates the hypothesis that among HIV-infected patients environmental enteropathy increase the risk of diabetes. The findings of this study will provide information which could be used as a basis for developing clinical trials to address different aspects of environmental enteropathy in order to reduce the burden of diabetes among HIV-infected populations

NCT ID: NCT03708380 Not yet recruiting - Diabetes Clinical Trials

Diabetes Prevention for Black Men

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Geographic analyses of diabetes burden have found that poor glycemic control, high rates of diabetes-related hospital utilization, and a high prevalence of microvascular diabetic complications all cluster in the same neighborhoods.This proposed study seeks to identify Black barbers with undiagnosed diabetes or prediabetes using point-of-care HbA1c testing, perform qualitative interviews to identify health behaviors that may explain poor sugar control, and develop a workplace-based food intervention to promote primary prevention and test its effect on sugar control in these individuals.

NCT ID: NCT03706378 Active, not recruiting - Diabetes Clinical Trials

Food Modification to Alter Glycaemia and Insulinaemia

Start date: August 18, 2017
Phase: N/A
Study type: Interventional

The study specifically aims to determine glycemic and insulinemic response of added low GI ingredients, beta-glucan, resistant starch and isomaltulose to foods.

NCT ID: NCT03703869 Recruiting - Diabetes Clinical Trials

Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.

ATOS
Start date: March 6, 2018
Phase:
Study type: Observational

Primary Objective: Assess effectiveness of insulin glargine (U300) in achieving glycemic goal measured by hemoglobin A1c (HbA1c). Secondary Objectives: - Assess effectiveness in achieving glycemic goal measured by HbA1c; - Assess effectiveness on change in HbA1c, fasting plasma glucose (FPG) and self-monitored plasma glucose (SMPG) ; - Assess requirement for intensification of therapy by additional antidiabetics. - Assess incidence of hypoglycemia; - Assess other safety endpoints: adverse events (AEs), serious adverse events (SAEs); - Assess change in body weight.

NCT ID: NCT03703544 Active, not recruiting - Diabetes Clinical Trials

The Glycaemic Response of Local Foods Using the Continuous Glucose Monitoring System

Start date: December 15, 2017
Phase: N/A
Study type: Interventional

This study is carried out to determine the effect of high and low GI of local foods using Continuous Glucose Monitoring System (CGMS™) on 24 hour blood glucose profiles.

NCT ID: NCT03696797 Not yet recruiting - Diabetes Clinical Trials

Iron Reduction by Phlebotomy to Improve Diabetes Control

Start date: December 2018
Phase: N/A
Study type: Interventional

This is a treatment study to determine if reducing the body's iron stores by blood donation will improve diabetes control and other problems associated with diabetes such as fatty liver disease.

NCT ID: NCT03690778 Not yet recruiting - Diabetes Clinical Trials

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.

Start date: October 2018
Phase: Phase 1
Study type: Interventional

A randomized, open-label, single dose, crossover study to compare the pharmacokinetic characteristics of the co-administration of metformin SR and rosuvastatin and JLP-1310 in healthy male volunteers.

NCT ID: NCT03686423 Not yet recruiting - Diabetes Clinical Trials

Reversing Diabetic Peripheral Neuropathy Through Exercise

Start date: December 2018
Phase:
Study type: Observational

This cross-over design study proposes an innovative multinuclear MRI approach to gain mechanistic insight into the exercise-associated adaptations in lower leg muscle function and peripheral nerve integrity of patients with diabetic peripheral neuropathy (DPN). Currently, there are no therapies to prevent or reverse the progress of DPN. This study will use novel multinuclear MRI technology to understand how exercise affects skeletal muscle and peripheral nerve integrity and function in patients with DPN. This study will prescribe a 4-week non-exercise phase followed by a 10-week exercise program (with both aerobic and strengthening components) to 40 DPN patients who will receive personal supervision from health professionals.

NCT ID: NCT03678896 Completed - Diabetes Clinical Trials

Creative Writing for Type 2 Diabetes Management

CrewD
Start date: January 5, 2017
Phase: N/A
Study type: Interventional

This study is related to the development of a new model of Group Care for patients with Diabetes - the CrewD Program, incorporating close reading and creative writing in group education. A randomized trial was designed to evaluate this intervention.

NCT ID: NCT03677609 Enrolling by invitation - Hypertension Clinical Trials

Stanford Clinics Physician Mindset Training

Start date: January 4, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to test the efficacy of a novel intervention for physicians to increase awareness about interacting with patients with pre- diabetes, diabetes, and hypertension. The investigators will measure health outcomes in patients as well as patient and physician satisfaction at Stanford Corporate clinics. The doctor-patient relationship has been shown to positively impact not only patient satisfaction, but also patients' physiological health outcomes. Thus, the investigators hypothesize that improving the patient-provider relationship would increase physician efficacy in regards to communicating and mitigating long-term risks to patients at risk for or suffering from chronic illness. The present study develops and tests a mindset intervention for physicians aimed at helping physicians prioritize connecting with their patients both in addition to and in comparison with a communication skills training for physicians.